Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
Saved in:
| Title: | Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium. |
|---|---|
| Authors: | Vose JM; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Fu K; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Wang L; School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Yantai University, Yantai, China., Mansoor A; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada., Stewart D; Departments of Oncology and Medicine, University of Calgary, Calgary, Canada., Cheng H; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.; Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China., Smith L; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA., Yuan J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Qureishi HN; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Link BK; Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, Iowa, USA., Cessna MH; Department of Pathology, Intermountain Medical Center, Murray, UT, USA., Barr PM; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Kahl BS; Department of Medicine, Oncology Division, Washington University School of Medicine in St. Louis, St. Louis, MO, USA., Mckinney MS; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC, USA., Khan N; Department of Hematology/Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Advani RH; Division of Oncology, Stanford Cancer Institute, Stanford, CA, USA., Martin P; Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY, USA., Goy AH; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA., Phillips TJ; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI, USA., Mehta A; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Kamdar M; Division of Hematology, University of Colorado, Denver, CO, USA., Crump M; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada., Pro B; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, USA., Flowers CR; Division of Cancer Medicine, Department of Lymphoma-Myeloma, MD Anderson Cancer Center, Houston, TX, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Smith SM; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA., Stephens DM; Huntsman Cancer Institute at University of Utah, Salt Lake City, UT, USA., Bachanova V; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA., Jin Z; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Wu S; Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, China., Hernandez-Ilizaliturri F; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Torka P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Anampa-Guzmán A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Kashef F; Department of Pathology, University at Buffalo, Buffalo, NY, USA., Li X; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Sharma S; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Greiner TC; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Armitage JO; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Lunning M; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Weisenburger DD; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Bociek RG; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA., Iqbal J; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Yu G; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. guohuayu@qdu.edu.cn.; Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, China. guohuayu@qdu.edu.cn., Bi C; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Nebraska Medicine Fred and Pamela Buffett Cancer Center, 505 S 45Th St, Omaha, NE, 68105, USA. andy.bi@unmc.edu. |
| Corporate Authors: | North American Mantle Cell Lymphoma Consortium |
| Source: | Journal of hematology & oncology [J Hematol Oncol] 2023 Dec 16; Vol. 16 (1), pp. 122. Date of Electronic Publication: 2023 Dec 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-8722 |
|---|---|
| DOI: | 10.1186/s13045-023-01520-7 |
